About
CanSense develops a non-invasive blood test using laser spectroscopy and AI to enable early detection of bowel (colorectal) cancer and pre-cancerous polyps, aiming to reduce the need for colonoscopies.
Explore CanSense's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.